Isolated reports of intratumoral EGFR mutational heterogeneity often used less sensitive methods of detection or have been dismissed as MASI, i.e. heterogeneous distribution of mutant EGFR amplification within the tumor. The gene discussed is EGFR; the disease is neoplasm.